# Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

> **NCT00270517** · PHASE2 · UNKNOWN · sponsor: **Enanta Pharmaceuticals, Inc** · enrollment: 250 (—)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **DRUG:** EDP-420 / Duration of Treatment - 3 days
- **DRUG:** Telithromycin / Duration of Treatment - 7 days

## Key facts

- **NCT ID:** NCT00270517
- **Lead sponsor:** Enanta Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 250 (—)
- **Last updated:** 2006-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270517, "Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00270517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*